肝海绵状血管瘤(cavernous hemangioma of liver,CHL)是临床上常见的一种肝脏良性病变,以单发多见,男女之比为1:3,临床常无症状。肿瘤巨大可压迫周围脏器引起相应症状,并因肝脏张力升高,有肝破裂的危险。过去手术切除是治疗CHL的首选疗法,但现在肝动脉栓塞介入治疗以其创伤小、成功率高、中远期疗效好的特点,已成为CHL的主要治疗方法之一,得到广泛应用。在近几年开展肝动脉栓塞介入治疗的实践中,收治了一例特别巨大的CHL,采用分次治疗的方法取得了满意的疗效。 Hepatic cavernous hemangioma of liver (CHL) is a common clinical benign liver lesions, more often seen as a single, male to female ratio of 1: 3, clinically asymptomatic. Large tumor can cause oppression of the surrounding organs caused by the corresponding symptoms, and because of increased liver tension, there is the risk of liver rupture. Surgical resection in the past is the preferred treatment for CHL, but now the interventional treatment of hepatic artery embolization with its small trauma, high success rate, long-term efficacy of the characteristics of good, has become the main treatment of CHL, has been widely used. In recent years, the practice of interventional treatment of hepatic artery embolization, admitted to a particularly large CHL, the use of fractional treatment has achieved satisfactory results.